Descemet Membrane Endothelial Keratoplasty (DMEK)

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01206127` - DSAEK- Postoperative Positioning and Transplant Dislocation	N/A
Completed	`NCT00357435` - Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Completed	`NCT00543660` - Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)	N/A
Recruiting	`NCT02826174` - Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation

N/A

Completed

NCT00357435 - Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

Completed

NCT00543660 - Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)

N/A

Recruiting

NCT02826174 - Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00521898
Study type	Interventional
Source	Netherlands Institute for Innovative Ocular Surgery
Contact
Status	Completed
Phase	N/A
Start date	February 2005
Completion date	February 2020

Descemet Membrane Endothelial Keratoplasty (DMEK) — DMEK

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms